Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma

11 May 2020

Abstract excerpt

Neuroblastoma is a sympathetic nervous system tumor, primarily presenting in children under 6 years of age. The long-term prognosis for patients with high-risk neuroblastoma (HRNB) remains poor despite aggressive multimodal therapy. This report provides an update to a phase II trial evaluating DFMO as maintenance therapy in HRNB. Event-free survival (EFS) and overall survival (OS) of 81 subjects with HRNB treated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ion channel regulation and function
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32391579
DOI: 10.1002/ijc.33044

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastomaPMID 32391579Read ↗

Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastomaSemantic proximity Read ↗

Neuroblastoma: biology, prognosis, and treatment.Semantic proximity Read ↗

Neuroblastoma: paradigm for precision medicine.Semantic proximity Read ↗

Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.Semantic proximity Read ↗

The quest to develop an effective therapy for neuroblastomaSemantic proximity Read ↗

Neuroblastoma: Molecular Pathogenesis and TherapySemantic proximity Read ↗

Neuroblastoma.Semantic proximity Read ↗

Neuroblastoma: A Tough Nut to Crack.Semantic proximity Read ↗

Advances in Risk Classification and Treatment Strategies for NeuroblastomaSemantic proximity Read ↗

Emerging clinical and research approaches in targeted therapies for high-risk neuroblastomaSemantic proximity Read ↗

Tumor Microenvironment in Neuroblastoma and Immunotherapeutic Approaches: Towards More Effective TreatmentSemantic proximity Read ↗

Novel Therapies for Relapsed and Refractory NeuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.